Mayo Clinic researchers study new class of drugs to treat multiple myeloma

PHOENIX --?Mayo Clinic researchers are studying a new class of immunotherapy drugs called "bispecific antibodies" that have demonstrated potent tumor-killing activity in multiple myeloma. A paper highlighting this work was published in Blood Cancer Discovery. "CAR-T (chimeric antigen receptor-T cell therapy) cell therapy, which uses a patient's own modified immune cells to kill cancerous tumors, [...]
Source: Mayo Clinic Arizona News - Category: Hospital Management Source Type: news